Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal types of tumors, and its incidence is rising worldwide. Survival can be improved when tumors are detected at an early stage; however, this cancer is usually asymptomatic, and the disease only becomes apparent after metastasis. Several risk factors are associated to this disease. Chronic pancreatitis, diabetes, and some infectious disease are the most relevant risk factors. Incidence of PDAC has increased in the last decades. It is hypothesized it could be due to other acquired risk habits, like smoking, high alcohol intake, and obesity. Indeed, adipose tissue is a dynamic endocrine organ that secretes different pro-inflammatory cytokines, enzymes, and other factors that activate oxidative stress. Reactive oxygen species caused by oxidative stress, damage DNA, proteins, and lipids, and produce several toxic and high mutagenic metabolites that could modify tumor behavior, turning it into a malignant phenotype. Anti-oxidant compounds, like vitamins, are considered protective factors against cancer. Here, we review the literature on oxidative stress, the molecular pathways that activate or counteract oxidative stress, and potential treatment strategies that target reactive oxygen species suitable for this kind of cancer.
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal types of tumours, and its incidence is rising worldwide. Although survival can be improved by surgical resection when these tumours are detected at an early stage, this cancer is usually asymptomatic, and disease only becomes apparent after metastasis. Several risk factors are associated with this disease, the most relevant being chronic pancreatitis, diabetes, tobacco and alcohol intake, cadmium, arsenic and lead exposure, certain infectious diseases, and the mutational status of some genes associated to a familial component. PDAC incidence has increased in recent decades, and there are few alternatives for chemotherapeutic treatment. Endoplasmic reticulum (ER) stress factors such as GRP78/BiP (78 kDa glucose-regulated protein), ATF6α (activating transcription factor 6 isoform α), IRE1α (inositol-requiring enzyme 1 isoform α), and PERK (protein kinase RNA-like endoplasmic reticulum kinase) activate the transcription of several genes involved in both survival and apoptosis. Some of these factors aid in inducing a non-proliferative state in cancer called dormancy. Modulation of endoplasmic reticulum stress could induce dormancy of tumour cells, thus prolonging patient survival. In this systematic review, we have compiled relevant results concerning those endoplasmic reticulum stress factors involved in PDAC, and we have analysed the mechanism of dormancy associated to endoplasmic reticulum stress and its potential use as a chemotherapeutic target against PDAC.
RESUMENLa leucemia linfoblástica aguda es una neoplasia predominante en pediatría, corresponde al 11% de las leucemias. En Colombia hay una incidencia anual en adultos de 1 por cada 100.000 habitantes. La recaída testicular es rara alcanzando solo del 0.9 a 8.8% de todos los casos y representa un signo de recurrencia que puede ser confundida con otros padecimientos testiculares. Se reporta el caso de un paciente masculino de 23 años de edad, con cuadro de 2 meses de evolución consistente en dolor y aumento de tamaño testicular, posterior a trauma, con antecedente de leucemia linfoblástica aguda tratada hace 4 años. Se realiza ecografía testicular que sugiere hidrocele a tensión. Es llevado a cirugía, donde se aprecia testículo con características neoplásicas por lo cual se realiza orquiectomía. Resultado de anatomía patológica concluye masa 12 cm correspondiente a infiltración por leucemia aguda, CD10 y CD34 positivo y Tdt negativo.El testículo es considerado santuario de células leucémicas, sin embargo excepcionalmente puede observarse formación de una masa simulando un tumor testicular.Palabras clave: Leucemia-linfoma linfoblástico; neoplasias testiculares; leucemia. Testicular infiltration due to acute lymphoblastic leukemia presented as a testicular mass: a case report ABSTRACTAcute lymphoblastic leukemia is a common pediatric neoplasia, comprising 11% of all leukemias. In Colombia, the annual incidence in adults is 1 out of 100,000 people. Testicular relapse is rare (accounting for only 0.9-8.8% of all cases) and represents a sign of recurrence which can be confused with other testicular conditions. We report the case of a 23-yearold male with testicular pain and swelling for 2 months after a trauma, and a history of acute lymphoblastic leukemia treated 4 years before. A testicular ultrasound suggested tension hydrocele. The patient was taken to surgery where a testis with neoplastic features was observed. Therefore, an orchiectomy was performed. The pathological anatomy revealed a 12-cm mass consisting of infiltration by leukemic cells, showing a positive expression for CD19, CD10, and a negative expression for TdT.The testes are considered a sanctuary site for leukemic cells. However, the formation of a mass that mimic a testicular tumor may exceptionally be observed.
RESUMEN El trauma craneoencefálico (TCE) es una entidad común a nivel mundial; en el organismo humano ocurren una serie de eventos en el contexto del TCE, algunos son inmediatos y otros se generan con la evolución de la lesión y son consecuencia a su vez de la gravedad de la misma. Dentro de este entorno, en esta revisión narrativa hablaremos sobre la anemia asociada a TCE, una alteración altamente descrita en estos pacientes. How to cite this article Moscote-Salazar LR, Pulido-Gutierrez JC, Navas-Marrugo SZ, Alvis-Miranda HR, Cabeza-Morales M, Duarte-Misol D, Alcala-Cerra G. Anemia y Traumatismo Craneoencefálico: Implicaciones Fisiopatologicas Para El Tratamiento Neurocritico. Panam J Trauma Crit Care Emerg Surg 2015;4(1):16-22.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.